UM Programme Breakfast Meeting - Kidney Cancer Awareness Week

UM Programme Breakfast Meeting - Kidney Cancer Awareness Week

Join us for a light breakfast and informal talks about the latest research in kidney cancer.

By Cancer Research UK Cambridge Centre

Date and time

Wednesday, February 7 · 8:30 - 9:30am GMT

Location

School of Clinical Medicine

Hills Road Cambridge CB2 0SP United Kingdom

About this event

This free event is for members of the CRUK Cambridge Centre.

We will be in Seminar Room 1 in the Clinical School. A light breakfast of pastries, fruit and hot drinks will be provided.


Rationale for kidney cancer screening and how we are taking on the challenge.

Professor Grant Stewart – Urological Malignancies Programme Co-Lead

Every patient with a new kidney cancer asks why they had such vague or no symptoms. This has driven us to assess the potential for a kidney cancer screening programme. In this talk we will discuss the rationale for screening for kidney cancer and our work on this topic to date.


PREDICT Kidney: Development, validation and feasibility testing of a new prediction tool to promote informed decision-making about kidney cancer follow-up care.

Dr Hannah Harrison – Public Health Researcher

An introduction to our new NIHR project which aims to improve decision-making during kidney cancer follow-up. A brief outline of how we plan to develop and validate a new model to predict survival after kidney cancer surgery, how we will work with patients and clinicians to implement this model in an online tool and our plans to test the feasibility of using this new tool in urology clinics.

Organized by

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

Sales Ended